<SEC-DOCUMENT>0001683168-22-001762.txt : 20220318
<SEC-HEADER>0001683168-22-001762.hdr.sgml : 20220318
<ACCEPTANCE-DATETIME>20220318075855
ACCESSION NUMBER:		0001683168-22-001762
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		<ITEMS>06b
FILED AS OF DATE:		20220318
DATE AS OF CHANGE:		20220318
EFFECTIVENESS DATE:		20220318

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sunshine Biopharma, Inc
		CENTRAL INDEX KEY:			0001402328
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				205566275
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-437864
		FILM NUMBER:		22751083

	BUSINESS ADDRESS:	
		STREET 1:		6500 TRANS-CANADA HIGHWAY
		STREET 2:		4TH FLOOR
		CITY:			POINTE-CLAIRE
		STATE:			A8
		ZIP:			H9R 0A5
		BUSINESS PHONE:		514-426-6161

	MAIL ADDRESS:	
		STREET 1:		6500 TRANS-CANADA HIGHWAY
		STREET 2:		4TH FLOOR
		CITY:			POINTE-CLAIRE
		STATE:			A8
		ZIP:			H9R 0A5

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Mountain West Business Solutions, Inc
		DATE OF NAME CHANGE:	20071030

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	mountain west business solutions,inc
		DATE OF NAME CHANGE:	20070607
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0708</schemaVersion>

    <submissionType>D</submissionType>

    <testOrLive>LIVE</testOrLive>

    <primaryIssuer>
        <cik>0001402328</cik>
        <entityName>Sunshine Biopharma, Inc</entityName>
        <issuerAddress>
            <street1>6500 TRANS-CANADA HIGHWAY, 4TH FLOOR</street1>
            <city>POINTE-CLAIRE</city>
            <stateOrCountry>A8</stateOrCountry>
            <stateOrCountryDescription>QUEBEC, CANADA</stateOrCountryDescription>
            <zipCode>H9R 0A5</zipCode>
        </issuerAddress>
        <issuerPhoneNumber>(514) 426-6161</issuerPhoneNumber>
        <jurisdictionOfInc>COLORADO</jurisdictionOfInc>
        <issuerPreviousNameList>
            <previousName>Mountain West Business Solutions, Inc.</previousName>
        </issuerPreviousNameList>
        <edgarPreviousNameList>
            <previousName>Mountain West Business Solutions, Inc</previousName>
            <previousName>mountain west business solutions,inc</previousName>
        </edgarPreviousNameList>
        <entityType>Corporation</entityType>
        <yearOfInc>
            <overFiveYears>true</overFiveYears>
        </yearOfInc>
    </primaryIssuer>

    <relatedPersonsList>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Steve</firstName>
                <middleName>N.</middleName>
                <lastName>Slilaty</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>6500 TRANS-CANADA HIGHWAY, 4TH FLOOR</street1>
                <city>POINTE-CLAIRE</city>
                <stateOrCountry>A8</stateOrCountry>
                <stateOrCountryDescription>QUEBEC, CANADA</stateOrCountryDescription>
                <zipCode>H9R 0A5</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification>President, Chief Executive Officer and Chairman</relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Abderrazzak</firstName>
                <lastName>Merzouki</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>6500 TRANS-CANADA HIGHWAY, 4TH FLOOR</street1>
                <city>POINTE-CLAIRE</city>
                <stateOrCountry>A8</stateOrCountry>
                <stateOrCountryDescription>QUEBEC, CANADA</stateOrCountryDescription>
                <zipCode>H9R 0A5</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification>Chief Operating Officer</relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Camille</firstName>
                <lastName>Sebaaly</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>6500 TRANS-CANADA HIGHWAY, 4TH FLOOR</street1>
                <city>POINTE-CLAIRE</city>
                <stateOrCountry>A8</stateOrCountry>
                <stateOrCountryDescription>QUEBEC, CANADA</stateOrCountryDescription>
                <zipCode>H9R 0A5</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification>Chief Financial Officer and Secretary</relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Rabi</firstName>
                <lastName>Kiderchah</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>6500 TRANS-CANADA HIGHWAY, 4TH FLOOR</street1>
                <city>POINTE-CLAIRE</city>
                <stateOrCountry>A8</stateOrCountry>
                <stateOrCountryDescription>QUEBEC, CANADA</stateOrCountryDescription>
                <zipCode>H9R 0A5</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>David</firstName>
                <lastName>Natan</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>6500 TRANS-CANADA HIGHWAY, 4TH FLOOR</street1>
                <city>POINTE-CLAIRE</city>
                <stateOrCountry>A8</stateOrCountry>
                <stateOrCountryDescription>QUEBEC, CANADA</stateOrCountryDescription>
                <zipCode>H9R 0A5</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Andrew</firstName>
                <lastName>Keller</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>6500 TRANS-CANADA HIGHWAY, 4TH FLOOR</street1>
                <city>POINTE-CLAIRE</city>
                <stateOrCountry>A8</stateOrCountry>
                <stateOrCountryDescription>QUEBEC, CANADA</stateOrCountryDescription>
                <zipCode>H9R 0A5</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
        </relatedPersonInfo>
    </relatedPersonsList>

    <offeringData>
        <industryGroup>
            <industryGroupType>Pharmaceuticals</industryGroupType>
        </industryGroup>
        <issuerSize>
            <revenueRange>Decline to Disclose</revenueRange>
        </issuerSize>
        <federalExemptionsExclusions>
            <item>06b</item>
        </federalExemptionsExclusions>
        <typeOfFiling>
            <newOrAmendment>
                <isAmendment>false</isAmendment>
            </newOrAmendment>
            <dateOfFirstSale>
                <value>2022-03-10</value>
            </dateOfFirstSale>
        </typeOfFiling>
        <durationOfOffering>
            <moreThanOneYear>false</moreThanOneYear>
        </durationOfOffering>
        <typesOfSecuritiesOffered>
            <isEquityType>true</isEquityType>
            <isOptionToAcquireType>true</isOptionToAcquireType>
        </typesOfSecuritiesOffered>
        <businessCombinationTransaction>
            <isBusinessCombinationTransaction>false</isBusinessCombinationTransaction>
        </businessCombinationTransaction>
        <minimumInvestmentAccepted>0</minimumInvestmentAccepted>
        <salesCompensationList>
            <recipient>
                <recipientName>Aegis Capital Corp.</recipientName>
                <recipientCRDNumber>15007</recipientCRDNumber>
                <associatedBDName>None</associatedBDName>
                <associatedBDCRDNumber>None</associatedBDCRDNumber>
                <recipientAddress>
                    <street1>810 7TH AVE</street1>
                    <street2>18TH &amp; 22ND FLOOR</street2>
                    <city>NEW YORK</city>
                    <stateOrCountry>NY</stateOrCountry>
                    <stateOrCountryDescription>NEW YORK</stateOrCountryDescription>
                    <zipCode>10019</zipCode>
                </recipientAddress>
                <statesOfSolicitationList>
                    <state>CT</state>
                    <description>CONNECTICUT</description>
                    <state>NV</state>
                    <description>NEVADA</description>
                    <state>NY</state>
                    <description>NEW YORK</description>
                </statesOfSolicitationList>
                <foreignSolicitation>false</foreignSolicitation>
            </recipient>
        </salesCompensationList>
        <offeringSalesAmounts>
            <totalOfferingAmount>7998699</totalOfferingAmount>
            <totalAmountSold>7998699</totalAmountSold>
            <totalRemaining>0</totalRemaining>
        </offeringSalesAmounts>
        <investors>
            <hasNonAccreditedInvestors>false</hasNonAccreditedInvestors>
            <totalNumberAlreadyInvested>9</totalNumberAlreadyInvested>
        </investors>
        <salesCommissionsFindersFees>
            <salesCommissions>
                <dollarAmount>960000</dollarAmount>
            </salesCommissions>
            <findersFees>
                <dollarAmount>0</dollarAmount>
            </findersFees>
            <clarificationOfResponse>Includes non-accountable expense allowance of 2% of gross proceeds.</clarificationOfResponse>
        </salesCommissionsFindersFees>
        <useOfProceeds>
            <grossProceedsUsed>
                <dollarAmount>0</dollarAmount>
            </grossProceedsUsed>
            <clarificationOfResponse></clarificationOfResponse>
        </useOfProceeds>
        <signatureBlock>
            <authorizedRepresentative>false</authorizedRepresentative>
            <signature>
                <issuerName>Sunshine Biopharma, Inc</issuerName>
                <signatureName>/s/ Steve N. Slilaty</signatureName>
                <nameOfSigner>Steve N. Slilaty</nameOfSigner>
                <signatureTitle>Chief Executive Officer</signatureTitle>
                <signatureDate>2022-03-18</signatureDate>
            </signature>
        </signatureBlock>
    </offeringData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
